Assessing the thyroid autoimmunity association with recurrent aphthous stomatitis.
Aphthous stomatitis, recurrent
Autoimmune diseases
Thyroid diseases
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
30 08 2023
30 08 2023
Historique:
received:
28
01
2023
accepted:
17
08
2023
medline:
1
9
2023
pubmed:
31
8
2023
entrez:
30
8
2023
Statut:
epublish
Résumé
Recent investigations have highlighted autoimmune origins and abnormal immune responses; particularly those related to T cell-mediated immunity and elevated T lymphocyte cells in the oral mucosa. Therefore, we investigated the relationship between recurrent aphthous stomatitis (RAS) and autoimmune thyroid diseases (ATDs) in an Iranian population. A cross-sectional study was performed on 102 patients diagnosed with ATD (cases) and 102 healthy patients (controls) who had been referred for the routine dental treatment. All participants were asked for the history of RAS and their age, gender, other systemic diseases, medications, and frequency of RAS in a year. Matching was performed based on the propensity scores for age and sex. In addition, the number of lesions in each recurrence in both groups was assessed and compared. The type of thyroid disease has been assessed for case participants and has been confirmed by the endocrinologist. The chi-square test, t-test, and Mann-Whitney U test were used to analyze the data using SPSS 18. Patients with ATD had higher RAS than healthy controls (P = 0.040). ATD patients had 1.93 times more risk for RAS, and the frequency of RAS in a year was 3.15times higher in these patients (P = 0.011). Moreover, the frequency of RAS was higher in patients with hypothyroidism than in those with hyperthyroidism. However, there were no significant differences in the size and the number of lesions between the groups. The risk and frequency of RAS were significantly higher in patients with ATDs. This would provide valuable insights into the underlying mechanisms and potential treatment strategies for both conditions.
Sections du résumé
BACKGROUND
Recent investigations have highlighted autoimmune origins and abnormal immune responses; particularly those related to T cell-mediated immunity and elevated T lymphocyte cells in the oral mucosa. Therefore, we investigated the relationship between recurrent aphthous stomatitis (RAS) and autoimmune thyroid diseases (ATDs) in an Iranian population.
METHODS
A cross-sectional study was performed on 102 patients diagnosed with ATD (cases) and 102 healthy patients (controls) who had been referred for the routine dental treatment. All participants were asked for the history of RAS and their age, gender, other systemic diseases, medications, and frequency of RAS in a year. Matching was performed based on the propensity scores for age and sex. In addition, the number of lesions in each recurrence in both groups was assessed and compared. The type of thyroid disease has been assessed for case participants and has been confirmed by the endocrinologist. The chi-square test, t-test, and Mann-Whitney U test were used to analyze the data using SPSS 18.
RESULTS
Patients with ATD had higher RAS than healthy controls (P = 0.040). ATD patients had 1.93 times more risk for RAS, and the frequency of RAS in a year was 3.15times higher in these patients (P = 0.011). Moreover, the frequency of RAS was higher in patients with hypothyroidism than in those with hyperthyroidism. However, there were no significant differences in the size and the number of lesions between the groups.
CONCLUSION
The risk and frequency of RAS were significantly higher in patients with ATDs. This would provide valuable insights into the underlying mechanisms and potential treatment strategies for both conditions.
Identifiants
pubmed: 37649008
doi: 10.1186/s12903-023-03326-y
pii: 10.1186/s12903-023-03326-y
pmc: PMC10470142
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
611Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
J Formos Med Assoc. 2019 Mar;118(3):664-670
pubmed: 30348492
Nutrients. 2020 Jun 12;12(6):
pubmed: 32545596
J Stomatol Oral Maxillofac Surg. 2023 Feb;124(1S):101294
pubmed: 36162803
Medicine (Baltimore). 2020 Sep 18;99(38):e22214
pubmed: 32957357
Postepy Dermatol Alergol. 2013 Apr;30(2):96-102
pubmed: 24278055
Age (Dordr). 2012 Feb;34(1):195-201
pubmed: 21350816
J Oral Pathol Med. 2022 Sep;51(8):694-701
pubmed: 35637621
Cureus. 2020 May 13;12(5):e8094
pubmed: 32542149
BMC Oral Health. 2019 Jul 16;19(1):153
pubmed: 31311529
Oral Dis. 2021 Sep;27(6):1443-1450
pubmed: 33012087
J Eur Acad Dermatol Venereol. 2012 Feb;26(2):226-30
pubmed: 21435025
Mol Cell Proteomics. 2020 May;19(5):774-792
pubmed: 32024769
Braz Oral Res. 2017 Jan 05;31:e10
pubmed: 28076499
J Clin Exp Dent. 2018 Nov 01;10(11):e1109-e1114
pubmed: 30607229
Biomed Res Int. 2022 Oct 10;2022:5855067
pubmed: 36262968
J Formos Med Assoc. 2017 Jan;116(1):4-9
pubmed: 27793414
Int J Immunogenet. 2015 Dec;42(6):428-31
pubmed: 26385127